|
Volumn 53, Issue 12, 2000, Pages 1341-1345
|
FR191512, a novel anti-influenza agent isolated from a fungus strain no. 17415: II. Biological properties
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA GLUCOSIDASE;
ALPHA GLUCOSIDASE INHIBITOR;
ANTIVIRUS AGENT;
DRUG METABOLITE;
ENZYME INHIBITOR;
FR 191512;
HYMECROMONE;
NEW DRUG;
POLYPHENOL DERIVATIVE;
RIBAVIRIN;
SIALIDASE INHIBITOR;
UNCLASSIFIED DRUG;
VIRUS ENZYME;
VIRUS SIALIDASE;
ZANAMIVIR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIVIRAL ACTIVITY;
ARTICLE;
CELL STRAIN;
CONTROLLED STUDY;
CYTOTOXICITY;
DISEASE MODEL;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG ISOLATION;
EXPERIMENTAL ANIMAL;
FEMALE;
FUNGUS;
IN VITRO STUDY;
IN VIVO STUDY;
INFLUENZA VIRUS A;
MOUSE;
NONHUMAN;
NOSE INFECTION;
PRIORITY JOURNAL;
STRAIN DIFFERENCE;
VIRUS INFECTIVITY;
VIRUS INHIBITION;
|
EID: 0034521147
PISSN: 00218820
EISSN: None
Source Type: Journal
DOI: 10.7164/antibiotics.53.1341 Document Type: Article |
Times cited : (8)
|
References (10)
|